|
26
|
ARK Genomic Revolution ETF
|
314
|
+36
|
+13%
|
US$17.6억
|
|
|
27
|
|
311
|
-19
|
-6%
|
US$16.3억
|
|
|
28
|
|
308
|
+79
|
+34%
|
US$34억
|
|
|
29
|
|
303
|
-23
|
-7%
|
US$19.2억
|
|
|
30
|
|
270
|
+18
|
+7%
|
US$15.9억
|
|
|
31
|
Ultragenyx Pharmaceutical
|
267
|
-45
|
-14%
|
US$15.8억
|
|
|
32
|
|
264
|
-14
|
-5%
|
US$27.5억
|
|
|
33
|
|
246
|
+35
|
+17%
|
US$12.3억
|
|
|
34
|
|
241
|
-16
|
-6%
|
US$14.5억
|
|
|
35
|
|
237
|
+21
|
+10%
|
US$19.6억
|
|
|
36
|
|
219
|
+1
|
+0.5%
|
US$3.56억
|
|
|
37
|
|
218
|
-8
|
-4%
|
US$24.4억
|
|
|
38
|
|
216
|
+40
|
+23%
|
US$6.34억
|
|
|
39
|
|
211
|
-29
|
-12%
|
US$6.72억
|
|
|
40
|
|
205
|
-3
|
-1%
|
US$15.5억
|
|
|
41
|
|
204
|
-19
|
-9%
|
US$5.07억
|
|
|
42
|
|
202
|
+24
|
+13%
|
US$11.1억
|
|
|
43
|
|
202
|
-9
|
-4%
|
US$6.69억
|
|
|
44
|
|
198
|
-11
|
-5%
|
US$4.87억
|
|
|
45
|
|
197
|
-22
|
-10%
|
US$20억
|
|
|
46
|
|
195
|
+35
|
+22%
|
US$14.2억
|
|
|
47
|
|
186
|
-1
|
-0.5%
|
US$3.77억
|
|
|
48
|
|
185
|
-12
|
-6%
|
US$19.2억
|
|
|
49
|
|
184
|
-1
|
-0.5%
|
US$4.98억
|
|
|
50
|
|
176
|
+18
|
+11%
|
US$9.15억
|
|